|
|
![]() | ![]() | ![]() | ![]() |
SYT » Topics » The Resources Syngenta Devotes to Research and Development May Not Result in Commercially Viable ProductsThis excerpt taken from the SYT 20-F filed Mar 1, 2006. The Resources Syngenta Devotes to Research and Development May Not Result in Commercially Viable Products Syngentas success depends in part on its ability to develop new products. Research and development in the agribusiness industry is expensive and prolonged, and entails considerable uncertainty. The process of developing a novel crop protection product, plant variety or trait typically takes about six to ten years from discovery through testing and registration to initial product launch, but this period varies considerably from product to product and country to country. Because of the complexities and uncertainties associated with chemical and biotechnological research, compounds or biotechnological products currently under development may neither survive the development process nor ultimately receive the requisite regulatory approvals needed to market such products. Even when such approvals are obtained, there can be no assurance that a new product will be commercially successful. In addition, research undertaken by competitors may lead to the launch of competing or improved products which may affect sales of Syngentas new products. This excerpt taken from the SYT 20-F filed Mar 16, 2005. The Resources Syngenta Devotes to Research and Development May Not Result in Commercially Viable Products Syngentas success depends in part on its ability to develop new products. Research and development in the agribusiness industry is expensive and prolonged, and entails considerable uncertainty. The process of developing a novel crop protection product, plant variety or trait typically takes about six to ten years from discovery through testing and registration to initial product launch, but this period varies considerably from product to product and country to country. Because of the complexities and uncertainties associated with chemical and biotechnological research, compounds or biotechnological products currently under development may neither survive the development process nor ultimately receive the requisite regulatory approvals needed to market such products. Even when such approvals are obtained, there can be no assurance that a new product will be commercially successful. In addition, research undertaken by competitors may lead to the launch of competing or improved products which may affect sales of Syngentas new products. | EXCERPTS ON THIS PAGE:
|
| |||||||